scPharmaceuticals (SCPH) Short Interest Ratio & Short Volume $3.97 -0.07 (-1.73%) As of 07/3/2025 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock scPharmaceuticals Short Interest DatascPharmaceuticals (SCPH) has a short interest of 1.83 million shares, representing 3.64% of the float (the number of shares available for trading by the public). This marks a -12.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 373,512 shares to cover all short positions.Current Short Interest1,830,000 sharesPrevious Short Interest2,080,000 sharesChange Vs. Previous Month-12.02%Dollar Volume Sold Short$7.23 millionShort Interest Ratio4.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares52,790,000 sharesShort Percent of Float3.64%Today's Trading Volume184,541 sharesAverage Trading Volume373,512 sharesToday's Volume Vs. Average49% Short Selling scPharmaceuticals? Sign up to receive the latest short interest report for scPharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSCPH Short Interest Over TimeSCPH Days to Cover Over TimeSCPH Percentage of Float Shorted Over Time scPharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,830,000 shares $7.23 million -12.0%3.6%4.7 $3.95 5/31/20252,080,000 shares $7.36 million -18.1%4.4%4.9 $3.54 5/15/20252,540,000 shares $7.32 million +11.4%5.4%5.2 $2.88 4/30/20252,280,000 shares $5.81 million -54.8%N/A5.2 $2.55 4/15/20255,040,000 shares $13.31 million +4.6%10.7%11.4 $2.64 3/31/20254,820,000 shares $12.68 million -15.0%10.2%10.9 $2.63 3/15/20255,670,000 shares $17.18 million -9.7%12.0%13.2 $3.03 2/28/20256,280,000 shares $20.60 million +2.3%13.3%14.4 $3.28 2/15/20256,140,000 shares $22.60 million +9.5%13.0%16.9 $3.68 1/31/20255,610,000 shares $18.63 million -10.5%N/A13 $3.32 Get the Latest News and Ratings for SCPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20256,270,000 shares $21.95 million -2.9%N/A14.6 $3.50 12/31/20246,460,000 shares $22.87 million +9.1%N/A15 $3.54 12/15/20245,920,000 shares $18.88 million +3.7%N/A13.8 $3.19 11/30/20245,710,000 shares $20.67 million +4.6%N/A15.2 $3.62 11/15/20245,460,000 shares $18.89 million +32.2%N/A15.3 $3.46 10/31/20244,130,000 shares $17.14 million -4.0%N/A13.7 $4.15 10/15/20244,300,000 shares $18.32 million +2.1%N/A14.2 $4.26 9/30/20244,210,000 shares $19.20 million -0.9%N/A14.3 $4.56 9/15/20244,250,000 shares $23.33 million -15.0%N/A16.1 $5.49 8/31/20245,000,000 shares $25.45 million -4.4%N/A20.6 $5.09 8/15/20245,230,000 shares $26.46 million -8.3%N/A19.9 $5.06 7/31/20245,700,000 shares $28.67 million +0.7%26.1%24.7 $5.03 7/15/20245,660,000 shares $26.77 million -2.9%25.9%25.3 $4.73 6/30/20245,830,000 shares $25.36 million +0.9%26.7%26 $4.35 6/15/20245,780,000 shares $23.93 million +19.9%26.5%24.3 $4.14 5/31/20244,820,000 shares $18.85 million +1.3%22.1%19.2 $3.91 5/15/20244,760,000 shares $21.75 million -1.7%21.8%19.9 $4.57 4/30/20244,840,000 shares $21.63 million +1.3%17.8%23.3 $4.47 4/15/20244,780,000 shares $23.23 million +3.5%N/A21.6 $4.86 3/31/20244,620,000 shares $23.19 million -0.7%19.7%19.5 $5.02 3/15/20244,650,000 shares $27.11 million -2.9%19.8%19.2 $5.83 2/29/20244,790,000 shares $28.84 million +3.0%20.5%19.8 $6.02 2/15/20244,650,000 shares $26.41 million -0.4%19.9%14.5 $5.68 1/31/20244,670,000 shares $22.88 million -0.2%20.0%12.8 $4.90 1/15/20244,680,000 shares $27.94 million -1.3%19.9%13 $5.97 12/31/20234,740,000 shares $29.72 million -1.5%20.2%13.3 $6.27 12/15/20234,810,000 shares $27.51 million -26.1%20.4%13.7 $5.72 11/30/20236,510,000 shares $35.41 million -1.2%27.6%19.8 $5.44 11/15/20236,590,000 shares $33.21 million +0.9%28.0%27.8 $5.04 10/31/20236,530,000 shares $34.94 million -4.3%27.7%27.7 $5.35379 passengers walked away from this (Ad)Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists[See The Details Here] 10/15/20236,820,000 shares $42.35 million -0.2%29.0%29.2 $6.21 9/30/20236,830,000 shares $48.63 million -0.6%29.0%27.3 $7.12 9/15/20236,870,000 shares $48.23 million +2.4%29.2%23.6 $7.02 8/31/20236,710,000 shares $51.53 million -0.5%28.5%16.7 $7.68 8/15/20236,740,000 shares $53.65 million +10.1%28.7%15.6 $7.96 7/31/20236,120,000 shares $51.59 million -4.4%N/A13.7 $8.43 7/15/20236,400,000 shares $53.50 million +8.7%N/A14.5 $8.36 6/30/20235,890,000 shares $60.02 million +16.6%N/A12.8 $10.19 6/15/20235,050,000 shares $54.34 million +12.7%N/A11.4 $10.76 5/31/20234,480,000 shares $47.58 million +10.1%N/A12.8 $10.62 5/15/20234,070,000 shares $46.93 million +16.6%N/A9.6 $11.53 4/30/20233,490,000 shares $34.41 million +1.8%18.0%6.6 $9.86 4/15/20233,430,000 shares $32.83 million +3.6%17.6%6.1 $9.57 3/31/20233,310,000 shares $30.02 million +1.9%17.8%6.3 $9.07 3/15/20233,250,000 shares $22.39 million +3.8%17.5%6.4 $6.89 2/28/20233,130,000 shares $23.48 million -5.2%17.7%6.4 $7.50 2/15/20233,300,000 shares $30.53 million +73.7%16.4%6.8 $9.25 1/31/20231,900,000 shares $11.74 million +11.8%9.4%5.6 $6.18 1/15/20231,700,000 shares $10.78 million +36.0%8.4%7 $6.34 12/30/20221,250,000 shares $8.96 million +17.9%6.2%2.9 $7.17 12/15/20221,060,000 shares $6.87 million +122.7%5.1%2.3 $6.48 11/30/2022475,900 shares $3.49 million -20.3%2.7%1.1 $7.33 11/15/2022597,100 shares $3.93 million +23.9%3.4%1.5 $6.58 10/31/2022482,000 shares $2.57 million -22.9%3.4%1.4 $5.34 10/15/2022625,500 shares $3.38 million +221.9%4.4%1.9 $5.40 9/30/2022194,300 shares $1.27 million +67.5%1.4%0.7 $6.52 9/15/2022116,000 shares $545.20 thousand -3.3%0.8%2 $4.70 8/31/2022120,000 shares $702 thousand +15.9%0.9%1.4 $5.85 8/15/2022103,500 shares $669.65 thousand +14.9%0.8%1.3 $6.47 7/31/202290,100 shares $445.09 thousand -6.5%0.7%1.2 $4.94 7/15/202296,400 shares $491.64 thousand +4.8%0.7%1.4 $5.10 6/30/202292,000 shares $443.44 thousand -1.0%0.7%1.3 $4.82 6/15/202292,900 shares $431.06 thousand -1.7%0.7%1.2 $4.64 5/31/202294,500 shares $453.60 thousand -6.4%0.7%3.3 $4.80 5/15/2022101,000 shares $448.44 thousand -4.6%0.8%3.6 $4.44 4/30/2022105,900 shares $526.32 thousand +1.2%0.8%3.6 $4.97 4/15/2022104,600 shares $519.86 thousand -2.2%0.8%3 $4.97 3/31/2022107,000 shares $607.76 thousand -8.4%0.8%2.6 $5.68 3/15/2022116,800 shares $566.48 thousand -11.1%0.9%3 $4.85 2/28/2022131,400 shares $689.85 thousand +3.8%1.0%3.1 $5.25 2/15/2022126,600 shares $621.61 thousand -5.5%1.0%2.6 $4.91 1/31/2022133,900 shares $577.11 thousand +11.4%1.0%2.4 $4.31 1/15/2022120,200 shares $491.62 thousand -11.2%0.9%2.2 $4.09 12/31/2021135,400 shares $679.71 thousand -9.7%1.0%2.6 $5.02 12/15/2021149,900 shares $703.03 thousand +8.8%1.1%3.1 $4.69 11/30/2021137,800 shares $598.05 thousand -0.7%1.0%2.9 $4.34 11/15/2021138,700 shares $783.66 thousand -11.7%1.1%3.3 $5.65 10/29/2021157,100 shares $923.75 thousand +3.2%1.2%3.4 $5.88 10/15/2021152,200 shares $1.00 million -16.2%1.2%3.3 $6.59 9/30/2021181,600 shares $1.21 million +23.5%1.4%1.8 $6.65379 passengers walked away from this (Ad)Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists[See The Details Here] 9/15/2021147,000 shares $890.82 thousand -10.3%1.1%1.1 $6.06 8/31/2021163,900 shares $1.03 million -4.8%1.2%1.2 $6.27 8/13/2021172,100 shares $943.11 thousand -6.6%1.3%1.3 $5.48 7/30/2021184,300 shares $1.01 million -19.0%1.4%1.4 $5.48 7/15/2021227,500 shares $1.25 million +35.3%1.3%1.7 $5.50 6/30/2021168,200 shares $1.03 million -51.3%0.9%1.5 $6.11 6/15/2021345,200 shares $1.97 million -7.6%1.9%4.6 $5.70 5/28/2021373,700 shares $2.12 million -9.5%2.1%5 $5.66 5/14/2021412,900 shares $2.30 million +9.6%2.3%5.2 $5.58 4/30/2021376,800 shares $2.45 million +2.3%2.1%4.2 $6.49 4/15/2021368,400 shares $2.72 million +13.1%2.0%4.1 $7.38 3/31/2021325,600 shares $2.11 million +0.5%1.8%3.5 $6.48 3/15/2021324,000 shares $2.31 million +4.7%1.8%3.1 $7.13 2/26/2021309,500 shares $2.25 million +3.0%1.7%1.9 $7.27 2/12/2021300,500 shares $2.17 million +1.5%1.7%1.8 $7.23 1/29/2021296,200 shares $1.95 million -3.2%1.7%1.9 $6.58 1/15/2021306,000 shares $1.91 million +16.5%1.7%2 $6.23 12/31/2020262,700 shares $1.43 million +37.8%1.5%1.9 $5.43 12/15/2020190,700 shares $1.06 million -1.5%1.1%1.5 $5.54 11/30/2020193,600 shares $1.76 million -1.9%1.1%1.9 $9.10 11/15/2020197,300 shares $1.79 million -1.1%1.1%3.8 $9.08 10/30/2020199,400 shares $1.66 million -8.7%1.1%3.7 $8.35 10/15/2020218,400 shares $1.92 million -4.3%1.2%3.7 $8.79 9/30/2020228,100 shares $1.70 million -6.7%1.3%3.7 $7.45 9/15/2020244,400 shares $1.92 million +5.1%1.4%2.9 $7.87 8/31/2020232,600 shares $1.99 million -19.6%1.3%2.3 $8.56 8/14/2020289,400 shares $2.34 million -11.9%1.6%2.3 $8.08 7/31/2020328,400 shares $2.46 million +32.8%1.9%2.2 $7.50 7/15/2020247,300 shares $1.83 million +13.0%1.4%1.8 $7.39 SCPH Short Interest - Frequently Asked Questions What is scPharmaceuticals' current short interest? Short interest is the volume of scPharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 1,830,000 shares of SCPH short. 3.64% of scPharmaceuticals' shares are currently sold short. Learn More on scPharmaceuticals' current short interest. What is a good short interest ratio for scPharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SCPH shares currently have a short interest ratio of 5.0. Learn More on scPharmaceuticals's short interest ratio. What is a good short interest percentage for scPharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.64% of scPharmaceuticals' floating shares are currently sold short. Is scPharmaceuticals' short interest increasing or decreasing? scPharmaceuticals saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 1,830,000 shares, a drop of 12.0% from the previous total of 2,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does scPharmaceuticals' short interest compare to its competitors? 3.64% of scPharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to scPharmaceuticals: Chimerix, Inc. (4.27%), Avid Bioservices, Inc. (18.17%), Anavex Life Sciences Corp. (33.33%), Syndax Pharmaceuticals, Inc. (26.66%), ArriVent BioPharma, Inc. (25.85%), uniQure N.V. (14.71%), Immunome, Inc. (16.30%), Gyre Therapeutics, Inc. (8.67%), Xeris Biopharma Holdings, Inc. (12.27%), Cronos Group Inc. (1.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short scPharmaceuticals stock? Short selling SCPH is an investing strategy that aims to generate trading profit from scPharmaceuticals as its price is falling. SCPH shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against scPharmaceuticals? A short squeeze for scPharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SCPH, which in turn drives the price of the stock up even further. How often is scPharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCPH, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Chimerix Short Interest Avid Bioservices Short Interest Anavex Life Sciences Short Interest Syndax Pharmaceuticals Short Interest ArriVent BioPharma Short Interest uniQure Short Interest Immunome Short Interest Gyre Therapeutics Short Interest Xeris Biopharma Short Interest Cronos Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SCPH) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share scPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
